Introduction
The varicella-zoster virus (VZV) genome has been predicted to contain 67 distinct genes, 62 of which have counterparts in herpes simplex virus type 1 (HSV-1) based on amino acid sequence conservation (Davison & Scott, 1986; McGeoch et al., 1988) . Four of the five HSV-1 immediate early genes have homologues in VZV: those encoding Vmw175, Vmw63, Vmw68 and Vmwll0. Vmw175 is an essential protein with a central role in regulation of the HSV-1 transcriptional programme, and has been the subject of intense study (reviewed by Everett, 1987) . The VZV gene 62 protein is highly similar (Davison & Scott, 1985; McGeoch et al., 1986) and functionally analogous to Vmw175 (Felser et al., 1988; Disney & Everett, 1990) , and has been identified immunologically in infected cells (Felser et al., 1988; Forghani et al., 1990) . Vmw63 is an essential protein which regulates later phases of HSV-1 transcription (reviewed by Sandri-Goldin, 1991) . The VZV gene 4 protein shows limited similarity to Vmw63 (Davison & Scott, 1986) , and has been implicated in transcriptional regulation by transient expression studies (Inchauspe et al., 1989) . The VZV gene 63 protein is the counterpart of Vmw68 (Davison & Scott, 1985) , which affects the host range of HSV-1 in cell culture (Sears et al., 1985) .
Vmw110 is translated from a spliced mRNA that is specified by a gene containing two introns in the proteinencoding region (Perry et al., 1986) . The gene is not essential for virus growth in cell culture, but deletion 0001-0549 © 1992 SGM mutants are severely impaired at low m.o.i. (Stow & Stow, 1986) . Vmwll0 has been shown to activate transcription from several HSV-1 promoters, either alone or in conjuction with Vmw175 (reviewed by Everett, 1987) . The protein is phosphorylated (Ackermann et al., 1984) and located in the nuclei of infected cells (Pereira et al., 1977) . It has a predicted Mr of 78452, but migrates with an apparent Mr of 110000 on SDS-PAGE (Preston et al., 1978) . The VZV gene 61 protein (henceforth referred to as 61) has a predicted Mr of 50 913 (Davison & Scott, 1986) and shows a marginal degree of similarity to Vmwl 10 in a cysteine-rich region which has been proposed to be a zinc-binding domain (Perry et al., 1986) . This region is present at residues 116 to 156 of Vmwll0 and 19 to 57 of 61, and is also a feature of several euka~otic proteins (Freemont et al., 1991) . Thus, it is quite possible that the two proteins share some functional aspects, but differ in others. Indeed, Inchauspe et al. (1989) have indicated that 61 may function in transcriptional regulation, but as a repressor rather than as an activator. In this paper, we have characterized the mRNA and protein products of gene 61 using the techniques of nucleic acid mapping, expression in heterologous systems and antibody studies.
Methods

Cells and viruses.
Monolayers of CV-1 cells were grown in 5 % CO 2 at 37 °C in Dulbecco's modification of Eagle's medium supplemented with 4 mM-glutamine, 100 units/ml penicillin, 100 txg/ml streptomycin (Davison & Scott, 1986) has been inverted to orient the gene from le~ to right. 
Construction of plasmids.
Restriction endonuclease sites used for cloning are indicated on the DNA sequence shown in Fig. 1 . VZV fragments were prepared from a plasmid containing VZV KpnI fragment i (Davison & Scott, 1983) .
pDK1 was constructed for expression of residues 105 to 467 of 61 fused to the carboxy terminus of fl-galactosidase by ligating a fragment extending from the BgllI site to the AvalII site downstream from the 3' end of the gene into the vector pUR290 (Riither & M(iller-Hill, 1983) cut with BamHI and PstI.
pDK11 was constructed for expression of 61 in Escherichia coli by ligating a fragment extending from the NcoI site encoding residue 1 to the HindlII site into the vector pKK240-11 (Amman & Brosius, 1985) cut with Ncol and HindlII. pDK12, which expresse s the carboxyterminal portion of 61 (61C) from residue 230, was obtained by digesting pDKll with NcoI and religating, pDK13, which expresses the amino-terminal portion of 61 (61N), was generated by inserting the NcoI fragment encoding residues 1 to 230 into the vector pKK233-2 (Pharmacia) cut with NcoI. The construction encodes a protein consisting of the first 230 residues of 61 plus 19 additional vectorencoded residues at its carboxy terminus. pMJ520 was constructed for expression of 61 in vaccinia virus by inserting VZV KpnI fragment i into the KpnI site of vector pMJ601 (Davison & Moss, 1990) . This vector contains the virus thymidine kinase gene into which has been inserted a cassette comprising a synthetic strong late promoter upstream from a multiple cloning site and lacZ under the control of an early promoter. Sequences between the HindllI site downstream from gene 61 and the HindlII site in the vector were removed by digesting with HindlII and religating. Sequences between the upstream Sail site in the vector and the NcoI site encoding residue 1 were removed from the resulting plasmid by digesting with SalI and (partially with) Ncol, repairing the ends and religating. pMJ523 was constructed for expression of 61C in a similar manner by removal of sequences upstream from the internal NcoI site. pMJ537 was constructed for expression of 61N by removal of the sequence between the internal NcoI site and the HindllI site in pMJ520. This construct encodes a protein consisting of the first 230 residues of 61 plus 11 additional vector-encoded residues at its carboxy terminus.
Construction of vaccinia virus recombinants.
Recombinants expressing 61, 61N and 61C at late times in infection were prepared as described by Davison & Moss (1989) . They are denoted VV61, VV61N and VV61C, respectively.
Preparation of rabbit antisera against 61. The fl-galactosidase fusion protein was extracted from bacteria containing pDK1 following induction during the mid-log phase of growth by using 1 mM-IPTG for 2 h at 37 °C. The protein was purified using the method described by Steers et al. (1971 ) , except thatp-aminobenzyl 1-thio-fl-O-galactopyranoside-agarose (Sigma) was employed for affinity chromatography;
to the oligodeoxyribonucleotide used for primer extension analysis is marked by arrowheads. The ATTAAA element close upstream from the region in which polyadenylation is predicted to occur is marked by asterisks. The amino acid sequence of 61 is shown above the DNA sequence with residue numbers to the right; the cysteine-rich domain which is also present in Vmw110 is marked by dots.
1.5 mg protein was obtained per 1 of bacterial culture, but only about 10% was intact as judged by SDS-PAGE. This proportion was recovered even in the presence of several protease inhibitors.
Antisera against the purified fusion protein were prepared by Serotech Ltd., Oxford, UK. Two sandy halflop rabbits were initially injected subcutaneously with 0.8 mg fusion protein in 0-5 ml emulsified with an equal volume of Freund's complete adjuvant. The rabbits were boosted on days 28, 56 and 98 with 0.8 mg fusion protein in 0.5 ml emulsified with an equal volume of Freund's incomplete adjuvant. Final antisera were collected on day 125.
Radiolabelling of infected cells. For labelling VZV proteins with 3ss, 5 mm Petri dishes of VZV-infected cells showing 20 to 50% c.p.e, were incubated at 37 °C for 2 h in methionine-reduced medium containing 20% of the usual concentration of L-methionine and lacking FCS. The medium was then replaced with fresh methionine-reduced medium containing 100pCi/ml L-[35S]methionine (SJ204; Amersham), and incubation was continued for 8 to 10 h. For labelling with 32p, monolayers were incubated for 4 h in phosphate-free medium without FCS, and then with this medium supplemented with 100~tCi/ml [32p]orthophosphate (PBSI 1 ; Amersham).
For labelling vaccinia virus proteins with 35S, cells were infected with virus at a multiplicity of 10 and incubated at 37 °C for 1 h. The monolayers were then washed and overlaid with methionine-reduced medium containing I00 ~tCi/ml L-[asS]methionine and incubated at 37 °C for 16 to 20 h. For labelling with 32p, cells were incubated overnight in phosphate-free medium without FCS and then infected with virus at a multiplicity of 10 for 1 h. The monolayers were washed and overlaid with this medium containing 100 ~tCi/ml [32p]orthophosphate and incubated at 37 °C for 16 to 20 h.
lmmunoblotting. Infected cell monolayers were rinsed twice with cold PBS (170 mM-NaCI, 3.4 mM-KCI, 10 mM-Na2HPO4, 1.8 mM-KH2PO4 pH 7.2) and scraped into 1 ml PBS. Cells were pelleted by brief centrifugation in a benchtop microfuge at 4 °C, resuspended in 0.25 ml PBS, heated at 100 °C for 5 to 10 rain with 0.25 ml boiling mix (80 mMTris-HC1 pH 6-8, 2% w/v SDS, 0.1 M DTT, 10% v/v glycerol, 0.5 mMbromophenol blue) and stored at -20 °C. Bacterial extracts were prepared by inoculating 1 ml L broth with 50 p,1 of an overnight culture of the appropriate clone, incubating at 37 °C for 2 h and inducing with 1 mM-IPTG at 37 °C for 2 h. Bacterial pellets were washed with PBS and lysed as described above.
Immunoblotting was performed as described by Frame et al. (1987) , using antisera ata dilution of 1:10. Immune complexes were detected by binding to ~2SI-labelled Protein A.
Immunoprecipitation. Infected cell monolayers were washed twice with cold PBS and scraped into 0.5 ml 0.1 M-Tris HC1 pH 8, 10% (v/v) glycerol, 0.5% (v/v) NP40, 0.5% (w/v) sodium deoxycholate and 0-2 mM-PMSF. Lysed cells were incubated on ice for 1 h and then centrifuged for 10 min in a bench microfuge at 4 °C to pellet cell debris. The supernatant was stored at -20 °C. Immunoprecipitation was carried out as described by Murphy et al. (1989) .
Fractionation of cells infected with vaccinia virus recombinants.
Infected ceils were separated into cytoplasmic and nuclear fractions, and nuclei were extracted sequentially with buffers containing increasing concentrations of NaC1 by a modification of the method described by Piette et al. (1985) . Infected cell monolayers were washed with cold PBS and scraped into 1 ml PBS. Cells were pelleted by centrifugation at 2000 r.p.m, in a Beckman GPR centrifuge, resuspended in 1 ml buffer A (10 mM-HEPES-KOH pH 8.0, 50 mM-NaC1, 0.5 M-sucrose, 1 m~-EDTA, 0.5% v/v Triton X-100, 7mM-2-mercaptoethanol, 1 mM-PMSF) and lysed by Dounce homogenization. Nuclei were pelleted by centrifugation at 3000 r.p.m, for 10 min at 4 °C, washed twice with 1 ml buffer A, resuspended in 333111 buffer B (10mM-HEPES-KOH pH 8.0, 100mM-NaCI, 25% v/v glycerol, 0.1 mM-EDTA, 7mM-2-mercaptoethanol, 1 mM-PMSF) and placed in a rotary mixer for 15 min at 4 °C. The nuclear suspension was centrifuged at 3000 r.p.m, for 10 min at 4 °C and the pellet was resuspended in 333 pl buffer C (as buffer B, except that the NaCI concentration was 400 mM). After rotary mixing for 30 rain at 4 °C, the suspension was centrifuged at 5000 r.p.m, for 10 min at 4 °C. The pellet was resuspended in buffer D (as buffer B, except that the NaC1 concentration was 2 M), sonicated for 10 s at 0 °C in a Heat Systems-Ultrasonics W-380 cup-horn sonicator and centrifuged in a bench microfuge at 13000 r.p.m, for 20 min at 4 °C. The pellet was washed twice with 1 ml buffer B. Supernatants from each step were dialysed overnight at 4 °C against 500 ml buffer B with one change of buffer. Aliquots were heated with boiling mix for SDS PAGE, and the remainder of each fraction was stored at -20 °C.
Immunofluorescence. Cell monolayers were fixed and permeabilized as described by Randall & Dinwoodie (1986) . Incubation with antisera and fiuorescein isothiocyanate-conjugated goat anti-rabbit antibody (Sigma) was carried out at dilutions of 1:20 and 1:80, respectively. Slides were viewed using a Zeiss Axioplan Universal microscope and photographed using a Zeiss MC 100 camera with Kodak Tri-X-Pan 400 film.
Dephosphorylation of proteins in vitro. Dephosphorylation was performed as described by Smith et al. (1989) . Briefly, 30 Ixl cell extract was mixed with 30~tl 0.2M-Tris-HCI pH8-0, 101aM-ZnClz and incubated at 30 °C for 16 h in the presence or absence of 1 U calf intestinal phosphatase. Aliquots were subjected to immunoprecipitation or immunoblotting.
Gel electrophoresis of proteins. SDS PAGE was conducted using 9% (w/v) polyacrylamide gels cross-linked with 1:37.5 (w/w) N,N'-methylenebisacrylamide. Gels from immunoprecipitation experiments were fixed in 10% (v/v) acetic acid, 50% (v/v) methanol, treated with En3Hance (New England Nuclear), dried and autoradiographed using Kodak XS-6 film with a Dupont Cronex Lightning Plus intensifying screen at -70 °C.
Analysis ofRNA. Total cellular RNA was isolated from uninfected or VZV-infected cells using the acid guanidinium thiocyanate-phenolchloroform extraction procedure described by Chomczynski & Sacchi (1987) . Northern blotting of RNA electrophoresed on formaldehydeagarose denaturing gels was carried out as described by Sambrook et al. (1989) . Nitrocellulose sheets were probed with plasmids radiolabelled by nick translation. The 5' end of gene 61 mRNA was mapped by primer extension (Sambrook et al., 1989) coli and vaccinia virus recombinants. E. coli 61N was synthesized as a single species with an Mr of 36000 (lane 7; the artefactual bands with slightly higher and lower MrS were not detected in other experiments), whereas proteins produced by VV61N had Mrs of 36K to 39K (lane 8). However, direct comparison of size was complicated by the fact that the E. coli and VV61N proteins differ at their carboxy termini; the former is eight amino acid residues longer. There was no difference in mobility between 61C produced in E. coli or by VV61C (lanes 9 and 10). The proteins of higher Mr in these lanes are related to fl-galactosidase and its breakdown products, and are particularly noticeable owing to the amount of extract loaded. labelled VZV-infected cells showed recognition of a heterogeneous set of proteins by the anti-61 serum. The most abundant migrated with MrS in the region of 62K to 65K, but larger species were again detected ( Fig. 3 a, lane  4) . Proteins of similar size were precipitated from 32p_ labelled extracts (Fig. 3b, lane 4) , but not by a nonspecific rabbit antiserum (lane 2). These results indicate that 61 is present as a phosphoprotein in VZV-infected cells. Rather weak reactions were observed consistently, and presumably reflect low levels of 61 present in the extracts or low affinity of the antiserum in immunoprecipitation reactions. 3sS-labelled proteins were also specifically precipitated from cells infected with VV61, VV61N and VV61C, and these corresponded in Mr to proteins detected by immunoblotting (62K to 65K, 36K to 39K and 30K, respectively; Fig. 4a, lanes 2 to 4) . Each of these proteins was shown to be phosphorylated (Fig. 4b, lanes  2 to 4) , indicating that phosphate groups are present in at least two regions of 61. The amount of extract loaded for different recombinants cannot be considered to be equivalent, because different proportions of cells were detached from monolayers during infection. It appears, for example, that more cells were lost after infection with VV61N. Nevertheless, because samples of the same volume were loaded on corresponding lanes in Fig. 4 (a) and (b), the relative intensities of the 32p_ and 35S-labelled proteins indicate that 61N is much more highly phosphorylated than 61C. Therefore, it is likely that 61 is phosphorylated at multiple sites, the majority in the amino-terminal region.
Results
Expression of 61 by VZV and in heterologous systems
Dephosphorylation of 61 in vitro
To determine whether phosphorylation contributes to the greater Mr of 61 expressed in eukaryotic cells and to its size heterogeneity, 35S-and 32pqabelled extracts from cells infected with vaccinia virus recombinants were dephosphorylated using calf intestinal phosphatase and analysed by immunoprecipitation (Fig. 5 a) and immunoblotting (Fig. 5b) . The Mr of 61 was reduced by dephosphorylation, although only a proportion of phosphate groups were removed and a degree of size heterogeneity was retained (Fig. 5a, lanes 1 and 2) . In this experiment only a small amount of phosphorylated 61 N was detected before treatment, and the label was not detected after dephosphorylation (Fig. 5 a, lanes 3 and 4) . In contrast, phosphate groups on 61C were refractory, and the Mr was not altered (Fig. 5a , lanes 5 and 6). These results were confirmed by immunoblotting experiments, in which the Mrs of major forms of 61, 61N and 61C after treatment with phosphatase were 62000, 36000 and 30000, respectively (Fig. 5b, lanes 2,4, 6 ). The proportion of 61N in the higher Mr form (39000) prior to dephosphorylation was greater in most other experiments (data not shown). These results show that the size heterogeneity of 61 is due to phosphorylation in the amino-terminal region, and that phosphoamino acids in this region are more vulnerable to calf intestinal phosphatase than those in the carboxy-terminal region. The stronger reaction of the antiserum in immunoblots with dephosphorylated forms of 61 and 61N was noted in several experiments. This probably reflects the fact that the antisera were raised against a portion of 61 expressed in E. coli, in which 61 does not undergo processing similar to that which occurs in eukaryotic cells. Thus, phosphorylation of 61 in eukaryotic cells may mask antigenic sites present on the E. coli protein. Also, since antibodies are directed against only a portion of 61, it is likely that the region from residues 105 to 230 contains at least some of the amino acids whose phosphorylation results in the observed increase in Mr.
Subcellular localization of 61
Immunofluorescence experiments showed that 61 is located in a punctate pattern in the nuclei of cells infected with VV61 (Fig, 6a) . In VZV-infected cells, 61 was also detected in the nuclei, but in a more diffuse pattern (Fig. 6b) . 61 is apparently absent from nucleoli in VZV-infected cells, and this is probably also the case for VV61-infected cells. Fig. 6 (b) also shows several uninfected CV-1 cells. 61N was detected in the cytoplasm (Fig. 6c) , whereas 61C was located in a diffuse pattern in the nuclei (Fig. 6d) . Since the anti-61 serum was raised against a fi-galactosidase fusion protein, expression of figalactosidase by the vaccinia virus recombinants presented a potential problem in these experiments. However, the levels of interference by antibodies against fl-galactosidase were shown to be minimal by the use of antisera prepared against other fl-galactosidase fusion proteins and vaccinia virus recombinants expressing flgalactosidase, but not 61 (data not shown).
The results of immunofluorescence were confirmed by subcellular fractionation experiments (Fig. 7) . 61 was detected in the nuclei of cells infected with VV61, and was not eluted by sonication in the presence of 2M-NaC1 (Fig. 7a) . 61N was detected in the cytoplasmic fraction (Fig. 7 b) , but 61C was largely resistant to extraction from nuclei, only a minor proportion being solubilized in 2M-NaCI (Fig. 7c) . In each case, fl-galactosidase expressed by the recombinants was present in the cytoplasm. It is possible that the relative insolubility of nuclear 61 and 61C results from high levels of expression by the vaccinia virus recombinants. Attempts to detect 61 in fractionated VZV-infected cells were unsuccessful, presumably owing to low levels of antigen. 
Preliminary mapping of the gene 61 m R N A
A Northern blot of total cellular RNA extracted from uninfected or VZV-infected cells was probed with pDK 1 (Fig. 8a) . A single VZV-specific RNA species of approximately 1.8 kb was detected (lane 2). It was not detected when the parent plasmid, pUR290, was used as probe (data not shown). Primer extension of an oligodeoxyribonucleotide complementary to the proposed gene 61 mRNA (see Fig. 1 ) generated a product of approximately 70 nucleotides specifically from VZVinfected cell RNA (Fig. 8b, lane 2) . Thus, the proposed 5' end of gene 61 mRNA is located about 65 bp upstream from the translation initiation site (see Fig. 1 ). The size of the transcript is consistent with polyadenylation in the region predicted from sequence considerations, close downstream from the ATTAAA element shown in Fig. 1 (Davison & Scott, 1986 ).
Discussion
The existence of gene 61 was predicted from DNA sequence data on the basis of the presence of a leftwardoriented open reading frame containing 467 codons in the genome (Davison & Scott, 1986 (Forghani et al., 1990) . In contrast, the protein expressed by VZV or VV61 is larger and has a heterogeneous Mr of 62K to 65K. The difference in Mr between proteins expressed in prokaryotic and eukaryotic cells is due, at least largely, to phosphorylation at multiple sites, particularly in the amino-terminal region.
The protein is located in the nuclei of VZV-and VV61-infected cells. It is present in the latter in a distinct punctate distribution, whereas in the former the pattern is more diffuse. Similar results have been reported for Vmwll0, which gave punctate nuclear fluorescence when expressed by transfection of the Vmw 110 gene, but a more diffuse fluorescence when expressed in conjunction with Vmw175 (Gelman & Silverstein, 1986) . When expressed by recombinant vaccinia viruses, 61C gives a non-punctate nuclear fluorescence, whereas 61N remains in the cytoplasm. Therefore, sequences in the carboxy-terminal region of 61 are responsible for transport into or retention in the nucleus, and sequences in the amino-terminal region, which contains the potential zinc-binding domain, are required for punctate localization. The region responsible for nuclear localization of Vmwll0 expressed transiently is also located towards the carboxy terminus (Everett, 1988) .
The similarities between 61 and Vmw110 are in accord with the view that the two proteins may share some functional properties. The role of Vmw 110 as a transcriptional activator in HSV-1 infection has been investigated in detail (reviewed by Everett et al., 1991) . It may act either on its own or in conjunction with Vmw175, the trans-activating ability of which it enhances significantly. Inchauspe et al. (1989) have found in transfection experiments that a plasmid containing VZV genes 60 and 61 reduces expression of a marker gene (gene 36) from its basal level or from enhanced levels induced by the gene 62 and gene 4 proteins. Since there is no expectation or evidence that the HSV-1 counterpart of the gene 60 protein is involved in transcriptional regulation, these authors have suggested a potential role for 61 in repression of VZV transcription. In contrast, Cabirac et al. (1990) have found that 61 had no effect on expression of gene 36 or its HSV-1 counterpart, UL23, either alone or in conjunction with Vmw175 or the VZV gene 62 protein. These potentially conflicting results may be due to differences between experimental systems, particularly in the DNA fragments used as reporter promoters. More extensive investigations should resolve the confusion, and elucidate the functions of 61 in VZV infection.
Gene 61 is transcribed in VZV-infected cells to give a 1.8 kb RNA. This is consistent with the results of Reinhold et al. (1988) , who have mapped an appropriately oriented 1.8 kb RNA to the region of the genome containing genes 59, 60 and 61 by Northern blot analysis. Our transcript mapping data are consistent with initiation and polyadenylation of an unspliced mRNA of this size at the positions indicated in Fig. 1 . Since, however, the Vmwll0 mRNA is spliced, our data must be considered as preliminary because we have not systematically examined whether splicing occurs in transcription of gene 61. Nevertheless, we have noted in Fig. 1 that the proposed 5' end of the mRNA maps about 25 bp downstream from an excellent candidate TATA element, which is downstream from two potential CAAT sequences.
The Vmwll0 gene possesses several upstream elements essential for immediate early expression, such as the TAATGARAT sequence (Mackem & Roizman, 1982) . We examined carefully the region upstream of gene 61, but were unable to identify convincing examples of such elements. Thus, there is no indication from sequence data that gene 61 is an immediate early gene. Kinetic analysis of VZV gene expression is problematic because high titre cell-free virus of a satisfactory infectivity ratio cannot be prepared in cell culture. The two studies that have been carried out have identified different, but possibly overlapping, sets of immediate early proteins (Lopetegui et al., 1985; Shiraki & Hyman, 1987) . It is not clear whether any of these proteins correspond to 61. The possibility that gene 61 is not an immediate early gene has precedents. The counterpart of gene 61 in a related herpesvirus, pseudorabies virus, is an early gene (Cheung, 1991) , and transcription of the gene 61 homologue in equine herpesvirus 1 has not been detected under immediate early conditions (Gray et al., 1987; E. Telford, M. Watson, K. McBride & A. Davison, unpublished data) . In these respects pseudorabies virus and equine herpesvirus 1, each of which has a single immediate early gene (that encoding the counterpart of Vmw175; Fenwick & McMenamin, 1984; Gray et al., 1987) , are likely to be better analogues of VZV than is HSV-1.
